Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
There was no “cheerleading” or “campaign” in the immediately preceding post. And the fact is, with applications and companies at this stage yes, you’re right, when shorties put the squeeze on, you do not know when it will end, but I doubt very much it will approach where I bought most of my shares ever again. The reality is, while you suggest the turnaround may not happen fora long time, and you could be right to some degree, if weeks or months is a long time. However, the reality is, current circumstances do not justify the currently oversold position and I know multiple deep pocked buyers buying, of their own accord, in recent days.
The reality is, contrary to your post, no one knows what will turn a price around when a stock is oversold but has major news pending any day that would take it from not being a commercial entity, to having a monopoly on a new standard of care for a critical disease with virtually no really good options but this one.
So yeah, you can keep shorting into it or selling, at your own risk.
Even with big money behind it, that doesn’t reduce losses if the trial takes years. Big money might actually be more likely to increase the accumulated loss because there is less need to be frugal.
You clearly have no idea what you're talking about. It's pre-revenue. They are in the last part of the marathon for approval of a drug with amazing results, in the UK. Prior to approval for marketing, the drug regulator is allowing them to manufacture and sell the drug to citizens in their country, which is something you JUST DO NOT SEE... I've never seen it, as a general rule, in the way it is being done in this situation.
And no, it's not the CEO/CFO, it's the COMPANY. It's not SHE, it's common sense and a basic business requirement for where they are at this Tim. If you don't understand that, you have no business investing in any stock on any market. And you certainly shouldn't be claiming you understand anything about microcap biotechs, no matter how much time you claim you've been posting on bulletin boards. Sounds like you just trade based on putting out nasty information and fake news and manipulating retail.
I own shares I bought at much lower prices. No one pays me, I just enjoy torturing jerks who stalk investors and these small microchips I find interesting. I find it kind of therapeutic... It satisfies my desire for justice. If you notice, I mostly just address the idiocy of people who post false information and try to harangue investors out of their investments, but also my investments. I don't generally tell people to buy any particular stocks and in fact, these microcap biotechs are very stressful and risky, so most people should have a portfolio to balance all the risk out, recognizing that they can lose their entire investment with microcap biotechs, and not necessarily because the technology is bad or because the managers are bad. There are bad actors that mess with these companies for profit. No doubt it's stressful and particularly so when you have jerks swing trading them and trying to break these companies so that they can get valuable assets for cheap.
For me, I like the stock. I have money in it. I like the technology. So of course I am going to defend my investment from arsonists and delinquents who make money basically committing legalized theft and sabotage. Apparently, the regulators let mafia guys do protection rackets out in the open, in our securities markets... They mess with these companies unless they get protection in various forms.
Bullying people on bulletin boards... you think that makes you credible? Now that is about the dumbest thing I've read all day. Only someone without any real world knowledge or credibility would push their luck and fake ID so far.
You're such a mess. No one in their right mind other than scammers, scamming, post their account details on bulletin boards. It's a stupid practice and activity. And given that any "screen shot" can be manipulated, it's also BS when someone does it. It means nothing.
As for people's "success" because they are interested in this company and treatment, the reality is, this is a well regarded treatment by top doctors at top institutions. You're a nobody on a bulletin board trying to pretend you have the credibility to run the drug down and the other investors, but the reality is far, far from any reasonable truth. You're a nobody. And the drug and company have the credibility over you always.
Agreed, I did share it because it is validating and it shows there is excitement forming. It is common for other researchers not to acknowledge anyone else is doing anything similar out there… though I wish the writers did do some basic dd.
Yeah, but there is an amazingly enthusiastically similar few articles every year. Not sure where this discover was but that is often a feature. Meanwhile, right in front of them… but which they cannot see because not big pharma and penny stock…
Look at this, they’ve just discovered dendritic cells might be able to immunize people as a cancer immunotherapy!!!
Isn’t that fantastic!?
And look, “Czerniecki also found that intratumoral vaccination in mice effectively reduced tumor sizes, offering another promising option for patients in the future.26 “You can actually make this stuff disappear,” he said. “
The miracles never cease to amaze!
Cancer Vaccination as a Promising New Treatment Against Tumors
Vaccination has beaten back infections for more than a century. Now, it may be the next big step in battling cancer.
Adam Feuerstein is going to be so happy to hear that dendritic cells might work someday. Just needed a multiple billion dollar market cap and some payola* behind it.
No mention of DCVax or DCVax-L. I guess they haven’t heard of it.
But you know, Adam said DCVax-L was like grapefruit juice and “failed” and he speaks for all of the global regulatory agencies and is a primary source… so why mention DCVax?
The article says they had mouse tumors disappear!!! Someday!
*Payola, in the music industry, is the illegal practice of paying a commercial radio station to play a song without the station disclosing the payment.
You did not disprove what I said. Owner of shares is NOT CEO. The CEO clearly did not understand what they were doing and were researchers, not lawyers. I've explained before how Swiss Cantons and officials often say things that sound great but are total bull. I've had to parse through it directly with top swiss attorneys and international companies thinking they had something they did not have... The Swiss seem up and up, but they are used to basically being in their own little world and they do a lot of marketing to international business that is questionable about how they are basically free to do what they want in Switzerland. I say this will all due respect for Swiss people. I am close to many Swiss people. And moreover, the Swiss themselves are very regulated. It's a strange juxtaposition having such carefully self-regulated people in charge of a Wild West tax haven that likes to sometimes present itself as free with all kinds of other things.
Go to Switzerland and get that cutting edge stem cell treatment... that you can't get in your own country. That was a thing at one time.
So your notion that owning outranks management, is not a rebuttal and is certainly not true in the context of a publicly traded company on a major exchange, which is where they were. Your attempt to twist that common notion of ownership, falls not only flat, but it's naive and really beneath you. She had just taken a senior position on the board, and they thought since she was a lawyer with great experience, she could handle calls on this program. But she was not CEO and no person in her position would step on toes that way.
You said she "signed" the press release, but she is just the PR rep on it, so it lists her number. Anyone who has ever done anything with a private company like this knows that such PR's first go through the CEO and outside counsel. PR reps do not have ultimate responsibility for these releases, they just answer questions.
She was literally NOT the CEO. The PR lists in the 2nd paragraph. Granted, that my further due diligence suggests that they did have a more consequential approval initially, or thought they had one, reasonably. But Switzerland can be a bit kooky. The Swiss people that I know are quite eccentric.
"Dr. Alton Boynton, President and CEO of Northwest Biotherapeutics".
Contact, not the CEO. The CEO is responsible for all of those details. If you're the owner, you call the CEO. But the CEO makes things happen, not the contact on the press form. If you take on the role of PR person, you take your direction from the CEO. The CEO was behind the technology, so you defer. That's NORMAL. She was not in charge and you know it. But you can't help yourself. Your focus on this mistake from 2007, is pathological. Moreover, you never tell the full story. You only tell the parts that suit you.
It wasn't a scam.
If it was a scam, the SEC would have pursued them and prosecuted them. Nothing of the sort happened. Plaintiff's law firms did pursue them and they got a settlement as the company agreed it had screwed up. But they only got $1 million, because the company corrected their mistake as soon as they realized they had made a mistake.
The original Complaint charges NWBO and certain of its officers and directors with violations of the Exchange Act. The Complaint alleges that during the Class Period, NWBO issued materially false and misleading statements. NWBO issued a press release on July 9, 2007 entitled "World's First Therapeutic Vaccine for Brain Cancer Commercially Available to Patients in Switzerland." The release stated that NWBO received an "authorization for use" from the Swiss authorities and that "DCVax-Brain is the first commercially available therapeutic vaccine for such cancers. The Company intends to begin making the product available to patients in Q3 2007." A week later, on July 16, 2007, NWBO issued another press release explaining that the authorization it received was really just for import/export purposes, and was conditional even for those limited purposes. Northwest Biotherapeutics stated that the Swiss government has not yet reviewed DCVax for neither safety nor efficacy. NWBO's stock which traded up from $2.30 per share to as high as over $7 per share during the Class Period has since dropped to below $3 per share.
The reality is, NO SCAM would be worth that nonsense. Switzerland is a tiny market so no, not a "huge scam" either. That's ridiculous. It's dumb that you keep harping on this unfortunate chapter from 2007 that was resolved reasonably and resolved initially by the company publicly acknowledging that they misunderstood.
I will note however, that was not the full story. The company did take pains later to tell the fuller story in an SEC document. I'm not going to go into the details more. They did not understand just how complicated their task apparently would be in Switzerland, that things were about to change in Switzerland, etc. This happens at small companies like this.
If you recall, there was a little thing in 2007-2008 called the 2007 to 2008 financial crisis. Things came to a screeching halt. Further, they seem to have adapted, as your post fails to indicated that Phase II, with 147 patients, to a Phase 3, with around 330 patients, so if you look at the fuller details and story, it's a bit different than what you suggest.
Further, by the way that program referenced there in Switzerland was a compassionate use program, kind of like the German Hospital Exemption program that the company received approval for a few years later, I've subsequently found out, by other means. It's dated and impossible to link to. Switzerland switched jurisdiction for the program from the Bundesamt für Gesundheit (“BAG” or “Office Fédéral de la Santé Publique”), the agency mentioned in the PR, to Swissmedic around the time of this PR. So previously, BAG had responsibility for such programs, the Federal Office of Public Health, is a part of the Federal Department of Home Affairs in Switzerland and is also responsible for public health in Switzerland, including the regulation and oversight of medicinal products and healthcare services?.
Swissmedic, on the other hand, is the Swiss Agency for Therapeutic Products, which is responsible for the authorization and supervision of therapeutic products, ensuring they are of high quality, safe, and effective. At the time, the program the company had applied to was under BAG, but when the jurisdiction flipped it would have had to have reapplied for full approval, something that they could not do at that time. My understanding is that Switzerland was less regulated for cell and stem cell treatments at the time and then they realized that they needed to be generally more careful. This was happening with every regulator from Germany to the US, because clinics were popping up that were doing all kinds of strange and unapproved treatments. So what was a permissive environment, became, rather suddenly, less permissive. And unfortunately, getting good legal advice on such matters in Switzerland is not only very, very expensive, but even people acclaimed as "top lawyers" in my experience, seem to be fairly comfortable being very easy going because Switzerland had been this jurisdiction where a lot of stuff was not as regulated and was more low key than in many other jurisdictions. That's why they were such a favorite tax haven.
But nonetheless, this is distraction because the company clarified they made a mistake shortly after they made the mistake, it was not this massive "fraud" you suggest. Switzerland is an obscure and tiny country, relatively speaking, for drug approvals.
Shorts one day are claiming that approval in the UK, a much bigger market that provides access through the Commonwealth and other treaties to many other markets potentially, is "so small" that it won't help the share price at all, and then when they want to argue the opposite, the approval of a minor application that was mistakenly announced and then clarified a few days later in 2007, no less, is this giant scam. Try consistency.
Shortly after this event, it appears that the general counsel resigned as Chief Financial Officer and General Counsel of the Company, and as a member of the Board of Directors and all committees thereof, in August 2007,
As for LP's ownership, there is no indication that she dumped or even sold any shares during that period. Rather it appears that she kept putting money into the company.
Over the next two years, the board had a fair amount of turnover, board members left, it was expanded, new managers were brought in. Alton stayed CEO
LP did not become CEO until June, 2011. She brought in Les Goldman, who was a partner at Sadden Arps for over 30 years specializing in commercialization of technologies. So while a nice guy on those radio shows, serious experience at a major Wall Street firm. It was a rough situation, given the times and challenges for a company like this, so getting people to come over with such resumes was a major positive, regardless of what shorts may say about any of it today.
The New York law firm of Skadden, Arps, Slate, Meagher & Flom took advantage of some unemployed energy experts to set up an energy division in its Washington office. Starting Sunday as new partners (though presumably they won't be in the office until Monday) are Lynn Coleman, former deputy energy secretary; Les Goldman, former assistant secretary of international affairs at DOE; Douglas Robinson, former special assistant to the secretary of energy, and James A. Rogers, former assistant general counsel at DOE.
Given LP and her husband's deep ties to energy, that connection seems clear, but nonetheless, a big act of faith to step away from a big firm income and join this tiny company. People don't do that to do early access swiss drug scams. That's just ludicrous.
These people don't come into a "scam". Just ridiculous. You guys take advantage of the fact that retail doesn't know anything, people don't know how to do due diligence and you can throw anything at the wall and make it stick and destroy people and companies for profit.
I am clear. And if any regulator ever checked my accounts, they’d see I was not lying… I don’t think you can be so comfortable… since you don’t disclose a thing.
Yeah, even though none of that has to do with DCVax-L, since he did not have GBM, and was never, ever enrolled in the trial. But he tried to initially perpetrate a bit of a fraud by implication, that he was … when called out, at least he was honest that he never was in the trial, because he never had GBM. His doctors were simply being careful when they found the brain tumor and ultimately narrowed it down to being a different type of tumor.
But you really don’t know what to believe with such posters. Such stories are often made up entirely.
You’re rehashing false information, old information, like more than a decade old, under a former CEO, who was not found to have intentionally misled anyone; you are smearing a very well respected analyst who has won awards for accuracy and has never been alleged to be a pumper or website poster except by you, and generally you spread nonsense that is just vaguely filled with enough old allegations and nonsense that someone might easily be misled by it if they were looking for a reason to distrust other posters who take far more effort to be accurate and detailed.
There is no indication they need more shares any time soon, and neither is there any indication of anything but great care in developing and not overspending to create the manufacturing up to now. The CDMO was and has been an excellent way to isolate costs and risks beyond the development stage and to do so parsimoniously, with the help of a local regional development authority providing funding and a promise to provide certain technological services to other small researchers and developers in return. It is innovative and symbiotic in its approach, to the community and actually quite responsible. An incredibly admirable approach.
Meanwhile NWBO owns completely the Flaskworks technology that will be used to automate manufacturing in later stages.
The company has been working with MHRA for years. The new process starts before applications are even submitted. Long before it. No one has said, that I am aware, that any corners are being cut. And like u said, if you want to present yourself as a regulatory lawyer for shorts, that’s a thing.
But otherwise, making contrary arguments to arguments not ever made, is a kind of negative posting that is intended to discredit others without saying so… implying that things are being said and assumed that are not being said or assumed.
Concern trolling is a well known, well classified thing.
If you wish to claim status as a regulatory counsel, for shorts, please identify yourself and your interest. I am sure everyone is anxious to hear your proper disclosure, “Nemesis”, the “long investor” who posts only negatively under a name that literally means … “archenemy” and “retribution”…
Pretty sure there have been some other ID’s virtually the same, or similarly classical in nature that have had a similar bent that are now retired mostly, because they became ineffective as “disgruntled long posters”…
Your ID was born 3/4/24. You have 102 negative posts. You only post here.
Many if the investors here have been here for years and bought giant amounts of shares at .17 to .21, and the trial was successful. So I think our worries are not the same. If you have been here before, I do not recall you except as a negative poster. Secondly, as for betting it all on one stock, I encourage people to diversify myself. But people’s choice as to how to invest is their own choice, especially if they choose individual stocks and stocks on the OTC. Very high risk stocks.
So why do you come to this obscure bulletin board to preach? Seems suspicious. With your diversification message, you could preach on Twitter and reach a much, much broader investment community. There are many forums where that is true. Yet here you are. Talking to a very narrow set of people who are or may be interested only in this stick at any given moment.
Your posts are incredibly desperate and getting more and more so by the day and minute.
Keeping it vague and decades old, but newbies don’t know that, previous CEO, reference to vague past event, very desperate. And the emotion. Your posts read like a screaming weirdo.
They cannot help but lie. Their dedication firmly confirms their or their master’s financial interests. They may be paid, or they may have a stake in a short position, but very obviously people do not create a vocation that is 7 days a week, holidays especially included, on obscure message boards that are only for investors in this company, to undermine a company without compensation or the expectation of valuable consideration.
They do this against a treatment that is promoted as a breakthrough by some of the top research centers and researchers in the world including, UCLA, Kings College, University of Pennsylvania and Brown University.
That requires compensation or valuable consideration of some sort if they do not have a stake in a short position. Owning shares, that is a different thing. Claims of having no stake, are not credible and reveal deception. Being short at least would not be illegal. Claiming no stake and no compensation of any sort, seems like a blatant confession of ill motives.
Therefore these flies cannot in any sense be taken seriously. The lies flow with rapidity, and repetition. They raise fake issues, when they are refuted, they raise other fake issues, and when people forget the last set of arguments, they raise again the same previous arguments that were refuted, hoping the same people who refuted those arguments before, do not see their posts and refute them again with clear, obvious and irrefutable evidence. It’s a pattern of behavior and a practice that reveals regularized behavior of a disruptive sort intended to have a particular impact on shareholder value. I think it reveals illegal intentions, and certainly a kind of vandalism that should have a remedy of some sort. Let’s see how this suit gets resolved, and maybe we will see a new suit that reveals who, what, when and why.
I mostly agree with you. I don't agree on this. I think DCVax-L at 250,000 and even higher, is competitive with the early approvals of drugs like Keytruda that while generally very useful, had terrible side-effects and were for many, many more patients.
It's not that I want them to charge more than they should, but my research says 250,000 actually makes DCVax-L, per patient, given few side-effects, dispensable in a community setting and a longer term treatment that extends life, more affordable, overall, than drugs costing the same or more. So I think people puzzling over the pricing at this stage and the cost and how it's got to be so much less, are really just anticipating things that are not yet issues for approval and really inventing issues to explain away shadows that are invented for lack of other things to talk about.
And yeah, shorts exploit all of the fear mongering. But DCVax-L, even at that price, once covered, is very reasonable overall. And in the longer run, the company will likely figure out better ways to finance it for patients and distribute the cost over time, without trying to become a cancer charity. They actually do have to cover the costs of development to this point and further development. Things don't end on approval of DCVax-L for glioblastoma. All of that comes with more sophisticated operations and financial capabilities and with resources behind them. I do hope that they are planning and have more of a plan than they have revealed so far, though I do also recognize that large drug companies want something like mRNA vaccines rather than cellular treatments because they have never, ever liked the idea of cellular treatments. So they are, it appears, going to have to be dragged kicking and screaming into this era of cellular vaccines and treatments. They could have been far more helpful, and really, I suspect that to some large degree, they have enjoyed the tribulations and difficulties and hope to exploit them. But I hope the company has made some progress on that front.
$150,000 per year, and typically patients took it for up to 2 years.
2014 prices.
Obviously insurance covers a large part of it.
Optune is 21,000 per month, indefinitely, and where it is covered, insurance covers some large portion of that. That is $252,000 per year.
In my opinion, DCVax-L, even priced as is, or more, is not only better, but comes out way cheaper per month, likely. Especially if they charge some decent portion of it over time.
And Car-T is way more all in, including side-effects, hospital care and all of the ancillary costs that don't get included by some.
True, the Iron Mountain "safe storage" facilities where absolutely EVERYONE stores their documents, keep catching fire, in many places around the world. You'd think they'd be able to put in sprinklers and keep the fires from happening, especially when they are storing paper.
I posted that Car-T was not approved long ago. But the reasons are clear. It was costing $1 million to treat patients and the side effects were awful, which was a huge reason for the cost. Plus it’s NOT a cure for many patients. So yeah, it is limited to patients that need it. It’s not a general treatment. It costs immense sums to treat people with car-t, it can’t be given in a community setting, side effects can kill people, and when patients have those side-effects it mushrooms the cost and there is no certainty that it will work long-term.
UCLA clearly has stated publicly in PR documentation that that trial IS DCVax-L. ExW just likes to manufacture complexity. This has been clearly posted previously.
You’re a lawyer now? Don’t worry, she was a former senior regulator for the state of NJ and heads up a NYS Bar Committee. She has massive judgments under her belt. I am pretty sure she can handle it…
What was the last case you litigated for massive judgments?
I did not say you don’t calculate the warrants not all converted. That’s not all authorized shares. Trying to save a stupid argument, but it’s still a ridiculous argument.
As I said, the point made was like claiming the remaining checks in a checkbook are dollars. They’re not until they are issued and you need dollars to issue them.
Authorized shares are NOT issued shares. Simple, obvious, undeniable MATH.
News 
Market Data 
Discover 
AI
